BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9688312)

  • 1. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
    Hirose M; Yamaguchi T; Kimoto N; Ogawa K; Futakuchi M; Sano M; Shirai T
    Int J Cancer; 1998 Aug; 77(5):773-7. PubMed ID: 9688312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats.
    Akagi K; Sano M; Ogawa K; Hirose M; Goshima H; Shirai T
    Toxicol Pathol; 2003; 31(4):388-96. PubMed ID: 12851104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.
    Ogawa K; Hirose M; Sugiura S; Cui L; Imaida K; Ogiso T; Shirai T
    Nutr Cancer; 2001; 40(2):134-9. PubMed ID: 11962248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated with phenylethyl isothiocyanate.
    Sugiura S; Ogawa K; Hirose M; Takeshita F; Asamoto M; Shirai T
    Carcinogenesis; 2003 Mar; 24(3):547-53. PubMed ID: 12663517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Lina BA; Woutersen RA
    Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
    Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N
    Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
    Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited tumor-initiating activity of phenylethyl isothiocyanate by promotion with sodium L-ascorbate in a rat two-stage urinary bladder carcinogenesis model.
    Takagi H; Shibutani M; Uneyama C; Lee KY; Kato N; Inoue K; Hirose M
    Cancer Lett; 2005 Mar; 219(2):147-53. PubMed ID: 15723713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
    Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
    Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
    Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
    Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of chronic toxicity and carcinogenicity in rats of Wingstay 100, a rubber antioxidant/antiozonant.
    Iatropoulos MJ; Williams GM; Wang CX; Brunnemann KD; Leber AP
    Exp Toxicol Pathol; 1997 Aug; 49(3-4):153-65. PubMed ID: 9314049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.